option for the regeneration of diseased tissues and organs. However, the secure application of cell-based therapies for the treatment of renal failure requires exact information regarding the mechanisms
Cell-based therapy approaches have been shown to improve allogeneic hematopoietic cell transplantation (AHCT) outcome by reducing its severe toxic side effects, including graft rejection, acute and chronic graft-versus
promise, but results have been inconsistent, raising many fundamental questions regarding the feasibility of cell-based therapies. Actual clinical implementation will require a better understanding of the efficacy of…
compelling tool for studying molecular and morphological events in cells and tissues. Cell-based High-Content Screening (HCS) is an upcoming technique for the investigation of cellular processes and their
micro)environment. The next challenge for the future of (endogenous vs transplanted) stem cell-based therapies will be the development of new protocols for carefully weighting and tightly regulating
translationally attach fluorescent reporters, carbohydrates, or other functional groups onto purified target proteins. However, cell-based expression can limit the scope of such approaches. Purified and reconstituted…
response to the UDCA therapy. Mesenchymal stem cells (MSC) represent a promising tool for cell-based therapies of autoimmune diseases, with few adverse effects, because of their immunosuppressive properties
FTIR and their cellular uptake was assessed by utilising in vitro HeLa cell-based assays to determine how internalisation occurs and the pathways they follow in cells. Three families
anti-inflammatory effects at an early stage in the inflammatory cascade as demonstrated throughout cell-based in vitro, animal in vivo as well as in human pilot studies. Anti-diabetic
based inhibition of lymphoma proliferation, in this study, this compound was further evaluated in cell-based assays. Use of an IRAK4 inhibitor potently down-regulated the LPS-induced NFκB transcriptional
does no longer belong to cognate iKIR-HLA pair. The therapeutic effect of NK cell-based tumor immunotherapy is highly dependent on the sustained NK cell licensing
patient-specific information (initially genetics information) and/or the application of patient-specific cell-based therapies. The BioBlood project aims to deliver personalized healthcare through a â??step changeâ
freshly excised animal corneal, conjunctival or scleral tissues mounted in diffusion chambers. Furthermore, several cell-based models of varying complexity have been developed to overcome the problems of animal models
differentiating keratinocytes (without helper virus, autonomous replication) and in various forms of 293 cell-based assays with help from wild type adenovirus type 5 (wt Ad5) or Ad5 helper plasmid
from skin of AMD patients are a reliable and safe source for autologous cell-based therapy in AMD, and proposes important new information for development of novel drugs for treatment
Cell-based therapies (CBTs) are considered the effective approaches to treat liver failure. However, which cell type is the most suitable source of CBTs for acute liver failure
stem cells maintain their characteristic of staminality, suggesting that they could be applied for cell-based therapy to improve chronic scar tissue of the vocal cords
vitro- hepatic differentiation of USSCs, to improve their future application in cell-based therapies in patients with chronic liver diseases. Materials and Methods: USSCs were isolated from human cord blood
cell-based therapy is a promising approach to treat many degenerative diseases such as type 1 Diabetes Mellitus (T1DM). Besides the exclusive pharmacological treatment for T1DM a new approach
Cell-based therapy is a promising biological approach for the treatment of cartilage defects. Due to the small size of autologous cartilage samples available for cell transplantation in patients, chondrocytes
youth? effect for adult SDSCs possibly through providing specific microenvironmental cues, which will benefit cell-based cartilage engineering and regeneration. This study provides a novel and promising approach
future endeavors in skeletal regenerative medicine and with NELL-1, form a potential stem cell-based therapeutic with potentially increased safety, purity, identity, potency, and efficacy
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.